- Home
- MEGI vs NKTR Comparison
MEGI vs NKTR Comparison
Compare MEGI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MEGI | NKTR |
|---|---|---|
| Founded | 2021 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 709.4M | 807.8M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | MEGI | NKTR |
|---|---|---|
| Price | $13.75 | $36.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $111.83 |
| AVG Volume (30 Days) | 178.0K | ★ 1.0M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 11.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.63 | $6.48 |
| 52 Week High | $14.89 | $66.92 |
Technical Indicators
Market Signals| Indicator | MEGI | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 29.54 |
| Support Level | $13.48 | $41.51 |
| Resistance Level | $13.80 | $45.34 |
| Average True Range (ATR) | 0.16 | 2.02 |
| MACD | 0.02 | -0.29 |
| Stochastic Oscillator | 51.43 | 3.70 |
Price Performance
Historical ComparisonAbout MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.